Nano liposomes target liver receptor a2 (EphA2s) and dependent diagnostic

• 收藏
• 分享

专利权人:

메리맥 파마슈티컬즈, 인크.

发明人:

드러먼드 대릴 씨,키르포틴 드미트리 비,카모운 왈리드

申请号：

KR1020187025741

公开号：

KR1020180121905A

申请日:

2017.03.16

申请国别(地区):

KR

年份:

2018

代理人:

摘要：

The cancer cell expression containing the EphA2 positives for treating cancer that EphA2 targeting peptide-doxorubicins generate nano liposomes is more than about 3000 EphA2 receptors/unit. Method identification and treatment for differential diagnostic method EphA2 positive cancer patients are provided with EphA2 targets nanoliposome encapsulating docetaxel prodrug.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/